NLRC5 germline variants as potential pharmacogenomic markers for immune checkpoint inhibitors

Detalles Bibliográficos
Autor principal: Meng, Xiang-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10255023/
https://www.ncbi.nlm.nih.gov/pubmed/37277194
http://dx.doi.org/10.1136/jitc-2023-007255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10255023/
https://www.ncbi.nlm.nih.gov/pubmed/37277194
http://dx.doi.org/10.1136/jitc-2023-007255

Ejemplares similares